SCHEMBL29242296

SCHEMBL29242296

COc1ccc(Cl)c(C2C(=O)Nc3cccc(Cl)c32)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.42
PBRM1 Q86U86 1/20 0.41
TP53 P04637 1/20 0.40
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CDYL2 Q8N8U2 1/20 0.39
CDYL Q9Y232 1/20 0.39
TGM2 P21980 1/20 0.38
HTR5A P47898 2/20 0.38
HTR1A P08908 1/20 0.38
HTR1D P28221 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR7 P34969 1/20 0.38
HTR3A P46098 1/20 0.38
HTR6 P50406 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5431073 0.79 CDYL2 (0.43) TP53ALDH1A1GAASMN1; SMN2CDYL2
SCHEMBL29242299 0.79 TP53 (0.46) TP53SMN1; SMN2CDYL2CDYL
SCHEMBL29242339 0.74 PBRM1 (0.53) PBRM1ALDH1A1HTR5AHTR1AHTR1D
SCHEMBL4590075 0.74 HTR1A (0.48) TP53ALDH1A1GAASMN1; SMN2HTR5A
SCHEMBL29242312 0.70 PBRM1 (0.45) PBRM1TP53ALDH1A1HTTHTR5A
SCHEMBL29242316 0.70 PBRM1 (0.49) PBRM1ALDH1A1HTTSMN1; SMN2HTR5A
SCHEMBL24112229 0.69 HTR5A (0.51) PBRM1TP53GAAHTR5AHTR1A
SCHEMBL24112728 0.69 HTR5A (0.51) PBRM1TP53GAAHTR5AHTR1A
SCHEMBL24029073 0.69 HTR5A (0.47) PBRM1TP53ALDH1A1GAAHTT
SCHEMBL13431421 0.69 BRD4 (0.51) TP53ALDH1A1HTTSMN1; SMN2MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118221565-A 3-Aryl indol-2-one compound with anticancer activity and application thereof in preparation of medicines for treating cancers 常州大学 2024-06-21 CN disclosed